IPhO is pleased to announce the addition of two new student chapters, and our growing national network has now reached 50 schools of pharmacy!
In just the fifth year of operation, IPhO represents the fastest growing student pharmacist chapter network in the United States.
Congratulations to student pharmacists at the University of Michigan and The Ohio State University. IPhO now connects them to a national network of 4,000 student pharmacists with similar interests, as well as a national network of 425 industry fellows and 10,000 industry pharmacists.
Several more schools are in the late stages of filing their chapter applications and will soon join the growing national network.
To start a chapter at your school, visit here.
For the student benefits of joining IPhO, view the National Student Brochure here!
As the 2016-17 Fellowship year officially comes to an end, several IPhO National Fellows Council (NFC) members have successfully completed their industry fellowships/residencies and accepted their first full time industry positions. We recognize and congratulate them, and all the outgoing fellows, on this significant accomplishment!
Outgoing NFC Leaders
- Alex Wei, PharmD
- Matthew Schmidt, PharmD
- Joyce Cao, PharmD
- Vatche Demirjian, PharmD
- Nicholas Heath, PharmD
- Gediminas Pliura, PharmD
- Alisha Couto, PharmD
- Phil Armendi, PharmD
The 2016-17 Fellowship year has been a very successful one for the IPhO NFC. Not only has the NFC grown in its size and scope, they have significantly enhanced the services, features, and opportunities available to all 400+ fellows nationwide. Among their many accomplishments this year were:
- Created and successfully implemented the first national industry-focused Case Competition for student pharmacists
- Planned and executed the 4th Annual Midyear Networking Event, How to Get a Job Post-Fellowship
- Hosted multiple webinars supporting professional development of students and fellows
- Partnered with multiple pharmaceutical and biotechnology companies to advocate for pharmacists in the industry
- Developed a National Speakers Bureau to support remote student chapters and pharmacy schools
- Conducted and published research to characterize and raise awareness of all fellowship programs
We are grateful to all outgoing and returning IPhO NFC members for their tireless support and major contributions to IPhO as they have helped connect fellows of all programs nationally and advocated for the careers of fellows and industry pharmacists.
Authored by Vineeth Nair, PharmD, Co-Chief Fellow, IPhO National Fellows Council
The 2016-17 term has been an extremely exciting and productive period for our National Student Officers. We want to take this moment to acknowledge each of them and some of their numerous accomplishments. IPhO increased its national student leadership from three to six members this past year to support the continuing growth of our organization. During their tenure, the number of IPhO Student Chapters grew to 48! This growth would not have been possible without the tremendous commitment and quality of these student pharmacist leaders.
In addition, we are pleased to congratulate each of them on their acceptance to an industry fellowship program.
2016-17 IPhO National Student Officers
Bridgette Tran, PharmD
NSO, Chapter Management
Fellow, Daiichi- Sankyo Medical Affairs
- Yesterday 07:37 amRT @fwpharma: US budget office estimates Senate healthcare bill will leave 22 million more uninsured by 2026 https://t.co/Nzm1O1i3FI
- Yesterday 07:37 amRT @FiercePharma: After a painfully slow 2016, FDA's racking up drug approvals lickety-split https://t.co/foIzWo0TSM
- Yesterday 07:34 amRT @fwpharma: Merck & Co.'s experimental CETP inhibitor anacetrapib cuts major coronary events in study https://t.co/iWb9D2wAwg $MRK
- June 26, 2017 08:00 amRT @pharmalot: FDA to study whether enough doctors understand claims in ads for cancer drugs.. https://t.co/XdZAwkxYwd #pharma #cancer #onc…
- June 26, 2017 08:00 amRT @ThePharmaLetter: Eisai applies to extend marketable use of Lenvima https://t.co/D1fb66L9Wc
- June 26, 2017 08:00 amRT @fwpharma: EU advisory panel recommends approval of AVEO's Oncology's Fotivda for renal cancer https://t.co/8aJIQQQjL4 $AVEO
- June 26, 2017 07:58 amRT @EdwardFrankel: Today: @OHGTalent Fellowship Program launches - 11 Fellows with advanced degrees join network. Good luck Fellows! #PhD #…
- June 23, 2017 08:57 amRT @BayerPharma: #Breaking #CHMP recommends #EU approval of #Bayer second-line #HCC treatment #pharma https://t.co/ZtGzvfwBJy
- June 23, 2017 08:56 amRT @fwpharma: Senate Republicans unveil bill to repeal Affordable Healthcare Act https://t.co/NAOEpolXJm
- June 23, 2017 08:56 amRT @FiercePharma: FDA rejects Pfizer's Epogen biosimilar for a second time https://t.co/A9NONFcxvP $PFE
- June 23, 2017 08:56 amRT @medaffairssoc: #MAPS2017 Medical Affairs professionals are key to increasing trust with HCPs!
- June 23, 2017 08:56 amRT @fwpharma: Merck KGaA's oral multiple sclerosis therapy Mavenclad gains support from EU panel https://t.co/zwfEa1a6co
- June 22, 2017 08:29 amRT @ThePharmaLetter: . @US_FDA chief gives promises over #generics https://t.co/ogE4zrvpDz
- June 22, 2017 08:28 amRT @FiercePharma: Trump administration's proposal to lower prices might just raise them, critics say https://t.co/BZCmqQOz37
- June 22, 2017 08:28 amRT @pharmalot: Pharma discloses some payments to Canadian doctors, but critics want more.. https://t.co/1g4ENeS8EB #pharma $BMY $GSK $MRK $…
- June 22, 2017 08:28 amRT @fwpharma: Novartis' canakinumab cuts cardiovascular risk in late-stage study https://t.co/lVV26WBT3u $NVS
- June 21, 2017 10:47 amMAPS Meeting 2017 https://t.co/vvgtU3waVd
- June 21, 2017 08:43 amRT @medaffairssoc: What's in your toolkit? MAPS day 2 opening keynote... how to build best in class MA strategy. #MAPS2017 #medaffairs
- June 21, 2017 08:42 amRT @FiercePharma: Pfizer kicks off human testing with maternal GBS vaccine https://t.co/XA4Y0zHvo6 $PFE
- June 21, 2017 08:42 amRT @Novartis: Novartis advances #migraine program w/ EMA regulatory filing acceptance. https://t.co/bPLNyCF4oC